title: [Experimental methods in the treatment of multiple sclerosis--new possibilities and hopes].
abstract: Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system (CNS) leading to demyelinization. Although our knowledge on the pathomechanism of MS has evolved dramatically in recent years; however there is still no effective cure for MS. So far, non-specific immune suppressive agents are used to slow down the disease. Recently, there are many efforts to find a new method that would allow to control specifically unwanted immune response. It might be achieved by affecting antigen recognition or induction of "immune deviation".
authors.affiliation: Zakład Biologii Rozwoju Człowieka Collegium Medicum, Uniwersytetu Jagiellońskiego w Krakowie. mmszczep@cyf-kr.edu.pl
authors.forename: Marian
authors.initials: M
authors.lastname: Szczepanik
authors.forename: Monika
authors.initials: M
authors.lastname: Tutaj
authors.forename: Iwona
authors.initials: I
authors.lastname: Filipczak-Bryniarska
authors.forename: Krzysztof
authors.initials: K
authors.lastname: Bryniarski
mesh_terms: D000818:Animals; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D009103:Multiple Sclerosis / Q000188:drug therapy* / Q000503:physiopathology; D016896:Treatment Outcome
chemical_list: D000893:Anti-Inflammatory Agents; D007166:Immunosuppressive Agents